Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GP Plus Adebrelimab Versus GP Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy for High-risk Locoregionally Advanced Nasopharyngeal Carcinoma

NCT06455410 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT06455410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06455410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GP Plus Adebrelimab Versus GP Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy for High-risk Locoregionally Advanced Nasopharyngeal Carcinoma
Lead sponsor
Sun Yat-sen University
Phase
Phase 2
Overall status
Recruiting
Start date
June 18, 2024
Completion date
June 18, 2028
Enrollment
216 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

nasopharyngeal carcinoma